IEX Stock Recent News

Reference is made to the stock exchange notice on 15 May 2024 regarding the completion of a private placement and a potential subsequent offering on the same terms and conditions as in the private placement, directed towards eligible shareholders.

The board of directors of IDEX Biometrics ASA resolved on 14 August 2024 to issue 84,800 incentive subscription rights to a new individual contractor of IDEX Biometrics. The grant was made under the Company's 2024 Subscription rights plan. The exercise price of the subscription rights is NOK 1.37 per share, they vest by 25% per year, and will expire on 16 May 2029. Following the grant, there are 27,229,855 incentive subscription rights outstanding.

Oslo, Norway, and London, UK - 14 August 2024 – TaluCard, in collaboration with IDEX Biometrics and a London based issuer is launching its state-of-the-art biometric payment solution. This groundbreaking initiative is set to transform payment solutions with a strong focus on accessibility and security for all users, including those with visual impairments and members of the aging community.

Although the revenue and EPS for Idex (IEX) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

IDEX Corporation (NYSE:IEX ) Q2 2024 Earnings Conference Call August 1, 2024 10:30 AM ET Company Participants Wendy Palacios - Vice President, Investor Relations, FP&A Eric Ashleman - Chief Executive Officer & President Abhi Khandelwal - Senior Vice President & Chief Financial Officer Conference Call Participants Mike Halloran - Baird Vlad Bystricky - Citigroup Nathan Jones - Stifel Deane Dray - RBC Capital Markets Matt Summerville - D.A. Davidson Joe Giordano - Cowen Andrew Buscaglia - BNP Paribas Rob Wertheimer - Melius Research Operator Hello, and welcome to the IDEX Corporation Q2 2024 Earnings Conference Call and Webcast.

IDEX's (IEX) second-quarter 2024 net sales decrease 5% due to lower sales in the Fluid & Metering Technologies and Health & Science Technologies segments.

Idex (IEX) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $2.04 per share. This compares to earnings of $2.18 per share a year ago.

NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended June 30, 2024. “IDEX teams delivered strong execution in the second quarter, expanding margins sequentially despite stronger uncertainty-fueled macro headwinds,” said Eric D. Ashleman, IDEX Corporation Chief Executive Officer and President. “As we tune the portfolio for sustained growth performance, our business leaders are deploying focused resources to our bes.

Weakness in the HST and FMT segments and escalating operating expenses are likely to hurt IDEX's (IEX) second-quarter results.

Idex (IEX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.